Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$372,295
+$203,287 QoQ
Shares Held
27,557
+103.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Beacon Pointe Advisors, LLC holds $6,694,336 across 7 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
29,753 | $3,517,102 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,417 | $1,433,232 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
32,930 | $609,863 | |
| 4 | HLN |
Haleon plc
|
48,499 | $485,474 | |
| 5 | VTRS |
Viatris Inc
This page
|
27,557 | $372,295 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
60,500 | $251,075 | |
| 7 | BTAI |
BioXcel Therapeutics, Inc.
|
18,877 | $25,295 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $372,295 | 27,557 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $169,008 | 13,575 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $142,609 | 14,405 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $189,494 | 21,220 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $187,961 | 21,580 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $279,166 | 22,423 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $164,420 | 14,162 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $160,778 | 15,125 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $318,941 | 26,712 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $299,796 | 27,682 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $305,206 | 30,954 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $216,546 | 21,698 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $237,864 | 24,726 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $250,914 | 22,544 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $142,565 | 16,733 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $167,509 | 15,999 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $294,260 | 27,046 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $391,233 | 28,916 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $273,737 | 20,202 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $381,557 | 26,701 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $146,014 | 10,452 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $239,347 | 12,772 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||